Taken together, SCG3 expression was significantly higher in IDH-mutant/1p19q-codeleted gliomas than the other subtypes of glioma, and SCG3 transcriptional activity was decreased in the mesenchymal subtype of GBMs. This evidence concerns the gene IDH1 and central nervous system cancer.